2749 Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with recurrent or refractory ovarian cancer: A phase Ib trial reporting safety and clinical activity. (September 2015) - Disis, M.L.; Patel, M.; Pant, S.; Hamilton, E.P.; Lockhart, A.C.; Kelly, K.; Thaddeus-Beck, J.; Gordon, M.; Weiss, G.J.; Ejadi, S.; Taylor, M.H.; Chin, K.; et al.